{
    "code": "01014442",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01014442",
    "time": "2020-02-25 02:27:16",
    "許可證字號": "衛署藥製字第014442號",
    "註銷狀態": "已註銷",
    "註銷日期": "89\/05\/03",
    "註銷理由": "適應症變更改為外銷專用",
    "有效日期": "89\/03\/13",
    "發證日期": "67\/03\/13",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00101444208",
    "中文品名": "斯而比林注射液２５％",
    "英文品名": "SULPYRINE INJECTION 25% &quot;TAI YU&quot;",
    "適應症": "僅限阿司匹林（ＡＳＰＩＲＩＮ）、乙醯氨基酚（ＡＣＥＴＡＭＩＮＯＰＨＥＮ）等內服藥品及其它非藥物性解熱療法都無效或不能利用且有注射退燒針必要之高燒危急情況下，方可最後考慮使用",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產",
        "申請商名稱": "1402206200  臺裕化學製藥廠股份有限公司",
        "申請商地址": "新竹縣竹東鎮員山路１１巷１３弄１號",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2808200400",
            "成分名稱": "SULPYRINE (EQ TO DIPYRONE )",
            "含量描述": "500",
            "含量": "500.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "010144420001.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01014442&Seq=001&Type=9"
        }
    ]
}